全文获取类型
收费全文 | 2178篇 |
免费 | 137篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 43篇 |
妇产科学 | 23篇 |
基础医学 | 369篇 |
口腔科学 | 42篇 |
临床医学 | 110篇 |
内科学 | 400篇 |
皮肤病学 | 200篇 |
神经病学 | 282篇 |
特种医学 | 47篇 |
外科学 | 225篇 |
综合类 | 9篇 |
预防医学 | 70篇 |
眼科学 | 59篇 |
药学 | 175篇 |
中国医学 | 16篇 |
肿瘤学 | 231篇 |
出版年
2023年 | 9篇 |
2022年 | 7篇 |
2021年 | 38篇 |
2020年 | 29篇 |
2019年 | 34篇 |
2018年 | 64篇 |
2017年 | 49篇 |
2016年 | 58篇 |
2015年 | 42篇 |
2014年 | 59篇 |
2013年 | 74篇 |
2012年 | 109篇 |
2011年 | 116篇 |
2010年 | 58篇 |
2009年 | 77篇 |
2008年 | 123篇 |
2007年 | 133篇 |
2006年 | 115篇 |
2005年 | 137篇 |
2004年 | 135篇 |
2003年 | 128篇 |
2002年 | 141篇 |
2001年 | 55篇 |
2000年 | 41篇 |
1999年 | 44篇 |
1998年 | 35篇 |
1997年 | 26篇 |
1996年 | 30篇 |
1995年 | 19篇 |
1994年 | 12篇 |
1993年 | 20篇 |
1992年 | 33篇 |
1991年 | 29篇 |
1990年 | 24篇 |
1989年 | 42篇 |
1988年 | 24篇 |
1987年 | 24篇 |
1986年 | 14篇 |
1985年 | 17篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1970年 | 4篇 |
1969年 | 3篇 |
1967年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有2316条查询结果,搜索用时 27 毫秒
1.
2.
3.
Emi Yamazaki Katsuko Kikuchi Yoji Sasahara Michihiro Kono Masashi Akiyama Setsuya Aiba 《The Journal of dermatology》2020,47(1):58-60
A case of atopic dermatitis (AD) with X-linked agammaglobulinemia (XLA), which is one of the primary immunodeficiency diseases, is reported. A 12-year-old boy had suffered from dry skin and recurrent itchy eruptions since he was 2 years old, and he was diagnosed as having XLA at the age of 4 years. His total immunoglobulin (Ig)E level was 7 IU/mL, even with regular Ig replacement therapy. Furthermore, filaggrin (FLG) mutations known in the Japanese population were not found. His skin lesions were well controlled by the application of a mild-class topical steroid and a moisturizer, though he developed folliculitis due to Staphylococcus aureus infection during treatment with a strong-class topical steroid. This case suggests that the FLG mutation and IgE-mediated sensitization are not necessary to induce AD skin manifestation. 相似文献
4.
5.
Kim DM Koszeghy KL Badovinac RL Kawai T Hosokawa I Howell TH Karimbux NY 《Journal of periodontology》2007,78(8):1620-1626
BACKGROUND: Inflammatory and anti-inflammatory mediators may play a significant role in patients with gingivitis. The purpose of this study was to assess the short-term effects of the systemic administration of two different concentrations of aspirin (81 and 325 mg/day, by mouth) on clinical periodontal parameters and gingival crevicular fluid (GCF) levels of 15-epi-lipoxin A4 (15-epi-LXA4), lipoxin A4, leukotriene B4 (LTB4), prostaglandin E2 (PGE2), and interleukin (IL)-6 and -1beta in a sample of naturally occurring gingivitis patients. METHODS: At day 0, after initial screening for entry, baseline periodontal parameters, including bleeding on probing (BOP), periodontal probing depths (PDs), and plaque index (PI) were measured, and GCF was sampled from 12 intrasulcular sites with filter paper strips for the measurement of six types of inflammatory and anti-inflammatory mediators using competitive enzyme immunoassay and enzyme-linked immunosorbent assay (prevalues). Forty-seven subjects were assigned randomly to one of three treatment groups: placebo (15 subjects); aspirin, 81 mg (16 subjects); and aspirin, 325 mg (16 subjects) once daily. On day 7, subjects were recalled for the measurement of periodontal parameters and collection of GCF samples for the measurement of six types of mediators (postvalues). RESULTS: Changes in inflammatory and anti-inflammatory mediator levels were not statistically significant for any of the three treatment groups. However, when pre- and postvalues were compared in the subjects receiving aspirin, 325 mg, there was a negative trend in the relationship between 15-epi-LXA4 and PGE2, whereas the relationship between LTB4 and PGE2 was not as strong. This might indicate that the subjects responding to aspirin-mediated PGE2 suppression effects produced higher 15-epi-LXA4 in GCF than non-responders. No statistically significant differences in PD and PI between pre- and postvalues were found for any of the three treatment groups. However, the results demonstrated a significant increase in BOP when aspirin, 325 mg was compared to placebo (P <0.001) and aspirin, 81 mg (P = 0.001). CONCLUSIONS: Aspirin can have an affect on BOP in naturally occurring gingivitis patients. Although most of the inflammatory mediators did not show significantly detectable changes after aspirin treatment for 7 days, the trend of aspirin-associated increases of 15-epi-LXA4 implied that this recently discovered aspirin-dependent eicosanoid may be associated with the increased incidence of BOP observed in the subjects who received aspirin therapy. 相似文献
6.
Michael Manogue Mary Kelly † Sonia Bartakova Masaryk ‡ George Brown ‡ Frank Catalanotto ‡ Teo Choo-Soo ‡ Elis Delap ‡ Pavel Godoroja ‡ Ikuko Morio ‡ Jerome Rotgans ‡ Mare Saag ‡ 《European journal of dental education》2002,6(S3):53-66
This Working Section is concerned with evolving methods of assessment in dental education. It focuses on newer methods of assessment that might have relevance for broader application. Although it cannot provide answers to all the questions it raises, it is hoped that the contribution it makes is of value in the process of the development of a global network in dental education. 相似文献
7.
Hoshino Kento Anan Go Hirose Takuo Yamakoshi Seiko Tajima Ryo Sato Toshihiro Miyake Yuka Fukunaga Tsugumi Kato Toshiko Endo Akari Seki Takayuki Nakayama Shingo Oba-Yabana Ikuko Nakamura Hannah Tani Junichi Mori Takefumi 《Clinical and experimental nephrology》2022,26(8):835-841
Clinical and Experimental Nephrology - Peritoneal dialysis (PD) catheter malposition is one of the complications of renal replacement therapy. This study aimed to determine the preoperative factors... 相似文献
8.
Nakamura A Hasegawa M Ito H Minami K Koike K Habu-Tomita N Nanba K Hamaguchi K Noshi E Hashimoto H Nishino I Okabayashi Y Koyabu K Kihara T Iwamoto Y Inoue Y Narita M Suzuki T Kato A 《Journal of pain & palliative care pharmacotherapy》2011,25(4):318-334
Several clinical reports showed that adverse effect profiles are not the same in morphine, oxycodone, and fentanyl. The authors investigated whether the relationship between plasma concentrations for antinociceptive effect and for various pharmacological effects differed among oxycodone, morphine, and fentanyl under controlled experimental setting using animal models. Oxycodone induced constipation and an antinociceptive effect in a similar concentration-dependent manner, whereas morphine required approximately 9-fold higher plasma concentration for antinociceptive effect compared with that for constipation when 50% effective plasma concentration (EC(50)) levels were compared. The EC(50) values for inhibition of behavioral activity were 2.1-, 2.7-, and 1.3-fold higher than those for antinociceptive effect in oxycodone, morphine, and fentanyl, respectively. Respiratory inhibition was observed even at higher plasma concentrations in all three opioids, and the differences in the EC(50) values compared with those for antinociceptive effects were 234.5-fold (oxycodone), 233.1-fold (morphine), or 104.2-fold (fentanyl). These results showed that oxycodone, morphine, and fentanyl exhibited unique patterns of plasma concentrations required for different pharmacological effects. The different adverse effect profiles observed in a clinical setting appear to be resulted from, at least in part, distinct intrinsic pharmacological profiles among these μ-opioid receptor agonists. 相似文献
9.
Takashi Ando Yuichi Riku Akio Akagi Hiroaki Miyahara Mitsuaki Hirano Toshimasa Ikeda Hiroyuki Yabata Ryuichi Koizumi Chisato Oba Saori Morozumi Keizo Yasui Atsuko Goto Taiji Katayama Satoko Sakakibara Ikuko Aiba Motoko Sakai Masaaki Konagaya Keiko Mori Yasuhiro Ito Hiroyuki Yuasa Masayo Nomura Kristine Joyce L. Porto Jun Mitsui Shoji Tsuji Maya Mimuro Yoshio Hashizume Masahisa Katsuno Yasushi Iwasaki Mari Yoshida 《Brain pathology (Zurich, Switzerland)》2022,32(1):e13002
The striatonigral and olivopontocerebellar systems are known to be vulnerable in multiple system atrophy (MSA), showing neuronal loss, astrogliosis, and alpha-synuclein-immunoreactive inclusions. MSA patients who displayed abundant neuronal cytoplasmic inclusions (NCIs) in the regions other than the striatonigral or olivopontocerebellar system have occasionally been diagnosed with variants of MSA. In this study, we report clinical and pathologic findings of MSA patients characterized by prominent pathologic involvement of the hippocampus. We assessed 146 consecutively autopsied MSA patients. Semi-quantitative analysis of anti-alpha-synuclein immunohistochemistry revealed that 12 of 146 patients (8.2%) had severe NCIs in two or more of the following areas: the hippocampal granule cells, cornu ammonis areas, parahippocampal gyrus, and amygdala. In contrast, the remaining 134 patients did not show severe NCIs in any of these regions. Patients with severe hippocampal involvement showed a higher representation of women (nine women/three men; Fisher's exact test, p = 0.0324), longer disease duration (13.1 ± 5.9 years; Mann–Whitney U-test, p = 0.000157), higher prevalence of cognitive impairment (four patients; Fisher's exact test, p = 0.0222), and lower brain weight (1070.3 ± 168.6 g; Mann–Whitney U-test, p = 0.00911) than other patients. The hippocampal granule cells and cornu ammonis area 1/subiculum almost always showed severe NCIs. The NCIs appeared to be ring-shaped or neurofibrillary tangle-like, fibrous configurations. Three of 12 patients also had dense, round-shaped NCIs that were morphologically similar to pick bodies. The patients with Pick body-like inclusions showed more severe atrophy of the medial temporal lobes and broader spreading of NCIs than those without. Immunohistochemistry for hyperphosphorylated tau and phosphorylated TDP-43 revealed minimal aggregations in the hippocampus of the hippocampal MSA patients. Our observations suggest a pathological variant of MSA that is characterized by severe involvement of hippocampal neurons. This phenotype may reinforce the importance of neuronal alpha-synucleinopathy in the pathogenesis of MSA. 相似文献
10.
Synthetic glucocorticoids display a consistent anti-inflammatory action which are composite mechanisms through genomic and non-genomic pathways, or different types of cells and molecules. Also a wide range of doses of glucocorticoids can be allowed to show a demanded anti-inflammatory effect in many inflammatory diseases. 相似文献